Calcitonin gene-related peptide regulates mitogen-activated protein kinase pathway to decrease transforming growth factor β1-induced hepatic plasminogen activator inhibitor-1 mRNA expression in HepG2 cells

Biosci Biotechnol Biochem. 2014;78(5):787-90. doi: 10.1080/09168451.2014.910096.

Abstract

Transforming growth factor (TGF) β1-induced plasminogen activator inhibitor (PAI)-1 is one of factors associated with the development of hepatic fibrosis. Calcitonin gene-related peptide (CGRP) shows hepatoprotective effect during hepatic injuries, including fibrosis. However, the effects of CGRP on PAI-1 expression induced by TGFβ1 are unknown. In this study, we investigated the effect of CGRP on TGFβ1-induced PAI-1 expression and its regulatory mechanisms in HepG2 cells. CGRP inhibited TGFβ1-induced PAI-1 expression. H89, a protein kinase A inhibitor, abolished the inhibition of TGFβ1-induced PAI-1 expression by CGRP. TGFβ1 activated mitogen-activated protein kinase (MAPK), including extracellular signal-regulated kinase, c-jun NH2-terminal kinase, and p38, and this activation was abolished by CGRP. These results show that the CGRP-induced cAMP/PKA activation suppresses activation of MAPK induced by TGFβ1, leading to decreased PAI-1 expression in HepG2 cells.

Keywords: calcitonin gene-related peptide; hepatocytes; mitogen-activated protein kinase pathway; plasminogen activator inhibitor-1; transforming growth factor β1.

MeSH terms

  • Calcitonin Gene-Related Peptide / pharmacology*
  • Enzyme Activation / drug effects
  • Gene Expression Regulation / drug effects*
  • Hep G2 Cells
  • Humans
  • Isoquinolines / pharmacology
  • Liver / cytology
  • Liver / metabolism*
  • MAP Kinase Signaling System / drug effects*
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinases / metabolism*
  • Phosphorylation / drug effects
  • Plasminogen Activator Inhibitor 1 / genetics*
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Sulfonamides / pharmacology
  • Transforming Growth Factor beta1 / pharmacology*

Substances

  • Isoquinolines
  • Plasminogen Activator Inhibitor 1
  • RNA, Messenger
  • Sulfonamides
  • TGFB1 protein, human
  • Transforming Growth Factor beta1
  • Mitogen-Activated Protein Kinases
  • Calcitonin Gene-Related Peptide
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide